Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Nordic Nanovector ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Nordic Nanovector ASA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Nordic Nanovector ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Nordic Nanovector ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Nordic Nanovector ASA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nordic Nanovector ASA, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Nordic Nanovector Raises USD8.34 Million In A Financing Round 11
Nordic Nanovector Raises US$10 Million In Series A Financing 12
Nordic Nanovector Raises US$2.4 Million In Venture Financing 13
Partnerships 14
Nordic Nanovector Enters into Research Agreement with Heidelberg Pharma 14
Nordic Nanovector Enters into Partnership with LegoChem Biosciences 15
Nordic Nanovector Enters into Agreement with Areva Med 16
Nordic Nanovector Enters into R&D Agreement with Paul Scherrer Institute 17
Nordic Nanovector Enters into Co-Development Agreement with Affibody 18
Equity Offering 19
Nordic Nanovector Raises USD1.2 Million in Rights Offering of Shares 19
Nordic Nanovector Raises USD59 Million in Private Placement of Shares 20
Nordic Nanovector Completes IPO 21
Nordic Nanovector Raises USD7.7 Million in Rights Offering of Shares 23
Nordic Nanovector Raises USD41.7 Million in Private Placement of Shares 24
Nordic Nanovector ASA – Key Competitors 25
Nordic Nanovector ASA – Key Employees 26
Nordic Nanovector ASA – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Financial Announcements 28
Aug 22, 2018: Nordic Nanovector: results for the second quarter and first half 2018 28
May 30, 2018: Nordic Nanovector – Results for the First Quarter 2018 31
Feb 27, 2018: Nordic Nanovector- Results for the Fourth Quarter and Full Year 2017: Solid Performance Through 2017, Moving Forward With Pivotal Trial 32
Nov 22, 2017: Nordic Nanovector – Results for the Third Quarter 2017 34
Aug 23, 2017: Nordic Nanovector – Results for Second Quarter and First Half Year 2017 36
May 24, 2017: Nordic Nanovector: Results for First Quarter 2017 38
Feb 28, 2017: Nordic Nanovector: Results for Fourth Quarter and Full Year 2016 39
Corporate Communications 40
Jun 01, 2018: Nordic Nanovector Strengthens Management Team With Appointment of Maureen Deehan, PhD, as Head of Corporate Development and Strategy 40
May 30, 2018: Nordic Nanovector Names Rainer Boehm As Board Director 41
Apr 20, 2018: Nordic Nanovector Appoints Tone Kvale As Interim Chief Executive Officer 42
Apr 04, 2018: Nordic Nanovector announces that Luigi Costa will step down as Chief Executive Officer 43
Product News 44
01/04/2017: Nordic Nanovector to Present at Biotech Showcase 2017 44
Clinical Trials 45
Mar 15, 2018: Nordic Nanovector to Present Preclinical Data Highlighting the Anti-tumour Effect of Humalutin in Three Lymphoma Models at AACR 2018 45
Mar 17, 2017: Nordic Nanovector announces first patient dosed in Phase 1 study of Betalutin in diffuse large B-cell lymphoma, an aggressive form of NHL 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47
Nordic Nanovector ASA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Nordic Nanovector ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Nordic Nanovector ASA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Nordic Nanovector ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Nordic Nanovector ASA, Deals By Therapy Area, 2012 to YTD 2018 9
Nordic Nanovector ASA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nordic Nanovector Raises USD8.34 Million In A Financing Round 11
Nordic Nanovector Raises US$10 Million In Series A Financing 12
Nordic Nanovector Raises US$2.4 Million In Venture Financing 13
Nordic Nanovector Enters into Research Agreement with Heidelberg Pharma 14
Nordic Nanovector Enters into Partnership with LegoChem Biosciences 15
Nordic Nanovector Enters into Agreement with Areva Med 16
Nordic Nanovector Enters into R&D Agreement with Paul Scherrer Institute 17
Nordic Nanovector Enters into Co-Development Agreement with Affibody 18
Nordic Nanovector Raises USD1.2 Million in Rights Offering of Shares 19
Nordic Nanovector Raises USD59 Million in Private Placement of Shares 20
Nordic Nanovector Completes IPO 21
Nordic Nanovector Raises USD7.7 Million in Rights Offering of Shares 23
Nordic Nanovector Raises USD41.7 Million in Private Placement of Shares 24
Nordic Nanovector ASA, Key Competitors 25
Nordic Nanovector ASA, Key Employees 26
Nordic Nanovector ASA, Subsidiaries 27
List of Figures
Nordic Nanovector ASA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nordic Nanovector ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nordic Nanovector ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nordic Nanovector ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nordic Nanovector ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Nordic Nanovector ASA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Nordic Nanovector ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Nordic Nanovector ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9